Stem cells themselves are not a scam. Blood-forming stem cell transplants have been used for decades, and a small number of cell products have been approved for specific diseases. The problem is the marketing that presents stem cells as a treatment for almost any illness, an anti-aging treatment or a safe answer to any chronic condition, often at high prices and with claims that the evidence does not support. The more useful question is not "are stem cells a scam?" but "is this specific offer established medicine, a research study, or marketing?"

This article sets out the warning signs and the checks that separate legitimate care from sales pitches.

What the evidence and regulators say

The International Society for Stem Cell Research (ISSCR) tells patients that very few stem cell treatments have been shown to be safe and effective so far. Its guidance lists several warning signs, including:

  • Unproven treatments can cause harm. They can cause health problems and high costs, and they can make a person ineligible for a later legitimate clinical trial.
  • One treatment for many diseases is a red flag. A single cell treatment is unlikely to work for many unrelated conditions, so clinics offering the same cells for a wide range of illnesses warrant extreme caution.
  • Your own cells are not automatically safe. Handling, culturing and reinjecting cells carry risks.
  • Marketing and testimonials can mislead. Patient stories and clinic advertising are not scientific evidence.
  • Selling an experimental treatment is not the same as a clinical trial. ISSCR warns against expensive treatments that have not passed through clinical trials.

The US Food and Drug Administration (FDA) makes similar points. Its consumer information on regenerative medicine says the agency has received reports of blindness, tumor formation and infections linked to unapproved products. It states that these products "are often illegally marketed by clinics as being safe and effective." It also groups exosome products with unapproved stem cell products, and says that adverse events can be reported through its MedWatch program.

Where the approved uses are narrow

Approved uses are few and specific. In Japan, regenerative products have been approved for particular diseases, and in 2026 the first iPS cell-derived products were approved, one for severe heart failure and one for Parkinson's disease. Both approvals are conditional, time-limited and tied to those conditions. Any offer that claims a stem cell product for anti-aging, weight loss, general "immune boosting" or an unrelated chronic disease is outside what has been approved. For background on the iPS approvals, read Japan Approves the First iPS Cell–Derived Products.

A person in a light blue top reaching into a wall-mounted medical supply organizer above a desk with a keyboard, mouse, and barcode scanner.

Warning signs in marketing

What you hear What it usually means
"Stem cells can treat diabetes, cancer, high blood pressure, or make you younger" The claim goes well beyond any approved use. Ask for the study that supports it for your condition.
"Our stem cells have no side effects" Every medical procedure carries risk, including collection, culturing and injection.
"It is legal and effective in Japan" Legality depends on a filed plan for that exact treatment. Effectiveness depends on human evidence. These are different questions.
"No filing is needed, this is a wellness product" In Japan, a regenerative treatment requires a filed plan. Calling it a wellness product does not change that.
"Only a few places left, pay today for a discount" Time pressure to commit is a common sales tactic.
Price and "results" are discussed, but the cell source, processing place and risk class are not The information needed for an informed decision is missing.

Other signals deserve attention. These include a free health check or seminar followed by a sales pitch for a paid treatment, procedures done by non-medical businesses such as beauty salons or wellness centers, and side effects explained away as "detox" or a "healing reaction."

Exosome treatments

Exosomes are small vesicles that cells release. They are often extracted from stem cell culture fluid and marketed as anti-aging treatments. An exosome is not a stem cell, and the evidence for exosome products is weaker still. The FDA lists exosome products among the unapproved products it warns consumers about. If a clinic offers exosomes for skin, anti-aging or a chronic disease, ask for the clinical study behind the specific claim and for the product's regulatory status in the country where it is sold.

A person in a white protective suit and dark gloves handling a rack of vials in a pink-lit laboratory, with a microscope and glassware on a reflective surface.

Checks for a treatment in Japan

Japan has a specific law for clinic-based regenerative treatment, and that gives you concrete questions to ask:

  1. Has a plan been filed for this exact treatment? Under the Act on the Safety of Regenerative Medicine, a clinic must file a provision plan for each treatment with the MHLW before providing it, after review by a certified committee.
  2. What class is it? Donor-derived cells and iPS or ES cells are Class I. Cultured cells from the patient's own body are usually Class II. Many other techniques are Class III. The filed plan determines the class.
  3. Who reviewed it? Class II plans must be reviewed by a specially certified committee.
  4. Is consent written? Article 14 of the Act requires the physician to give an appropriate explanation and obtain consent. Ask for the explanation in writing.
  5. What happens after treatment? Serious adverse events must be reported to the committee and the government within 7 days (for deaths or cases that may lead to death) or 15 days (for other serious cases) under Article 35 of the Enforcement Regulations.

The penalties give a sense of how seriously Japan treats unfiled treatment. Under Articles 59 to 62 of the Act, providing Class I treatment without a filed plan can bring up to one year of imprisonment or a fine of up to one million yen, and Class II or III without a filed plan can bring a fine of up to 500,000 yen. The MHLW opened a reporting window for suspected violations and safety concerns on September 2026.

A filed plan shows that the clinic completed the legal process. It does not show that the treatment works or that it is safe for you.

What to do if you are unsure

Slow the decision down. Ask for everything in writing, and for the explanation document to be translated before you sign. If the clinic will not answer in writing, or says a question is not relevant, treat that as an answer. You can also send the clinic's name and the offer to our advisors, who can help you check whether a plan has been filed for that treatment and whether the offer matches it. For the broader framework, read How Japan regulates regenerative medicine. To see how the same questions apply to a specific clinic, read 10 questions to ask a Japanese clinic before regenerative treatment.

Two people facing each other against a pink background, one in a pink turtleneck with open hands and the other in a white lab coat with a stethoscope holding a clipboard

Frequently asked questions

Are stem cell treatments a scam?

Stem cells are not a scam. Blood-forming stem cell transplants are established medicine, and a few cell products are approved for specific diseases. The scams are in the promotion of stem cells as a treatment for almost any illness, an anti-aging treatment or a safe fix for any condition.

Are stem cell beauty or anti-aging treatments credible?

Be very cautious. Approved cell products are for specific diseases, not cosmetic or anti-aging use, and the evidence for anti-aging claims is weak. For details, read Stem cell therapy for anti-aging: evidence, risks and what shapes the cost.

Is an exosome treatment the same as a stem cell treatment?

No. Exosomes are vesicles released by cells, often taken from stem cell culture fluid. The FDA groups exosome products with unapproved stem cell products, and the evidence for exosome treatments is weaker.

If a clinic in Japan is legal, is it safe and effective?

Not necessarily. Legal means the clinic completed the filing for that treatment. Safety and effectiveness depend on human evidence and on the clinic's conduct, and the filing alone does not establish either.

What should I do if I think I have been misled?

Keep your records, invoices and written explanations, and write down what you were told and when. Adverse events can be reported to the FDA through MedWatch in the US. For concerns about a Japanese clinic, send the details to our advisors so they can help you organize the facts.

Sources: International Society for Stem Cell Research (ISSCR), "9 Things to Know About Stem Cell Treatments" (aboutstemcells.org), points 2, 4, 6, 7 and 8; US Food and Drug Administration, "Important Patient and Consumer Information About Regenerative Medicine Therapies" (fda.gov); Act on the Safety of Regenerative Medicine, Articles 4, 14 and 59 to 62; Enforcement Regulations, Article 35 (e-Gov, laws.e-gov.go.jp); MHLW, "Regenerative medicine, cell medicine and gene therapy" page (update of September 2026); Japan Science Portal (JST), 18 March 2026, on the iPS cell product approvals. Checked November 2026; MHLW and FDA publications prevail.

Medical disclaimer: This site provides general information only and does not constitute medical advice; whether any treatment is suitable for you must be decided by a doctor after an in-person consultation.